| 发明名称 |
4-{4-[(1E)-4-(2,9-diazaspiro[5.5]undec-2-yl)but-1-en-1-yl]-2-methylbenzyl}-5-(propan-2-yl)-1H-pyrazol-3-yl beta-D glucopyranoside acetate |
| 摘要 |
The present invention provides a compound of Formula I or hydrate thereof, useful for the treatment of diabetes.; |
| 申请公布号 |
US9573970(B2) |
申请公布日期 |
2017.02.21 |
| 申请号 |
US201415026427 |
申请日期 |
2014.10.30 |
| 申请人 |
Eli Lilly and Company |
发明人 |
Reutzel-Edens Susan Marie |
| 分类号 |
C07H17/02 |
主分类号 |
C07H17/02 |
| 代理机构 |
|
代理人 |
Lentz Nelsen L |
| 主权项 |
1. A compound of the formula: which is a crystalline hydrate. |
| 地址 |
Indianapolis IN US |
